337 related articles for article (PubMed ID: 3704666)
1. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
2. The bone marrow in polycythemia vera.
Ellis JT; Peterson P
Pathol Annu; 1979; 14 Pt 1():383-403. PubMed ID: 390480
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
5. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
[TBL] [Abstract][Full Text] [Related]
6. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
7. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
[TBL] [Abstract][Full Text] [Related]
9. Acute leukemia in polycythemia vera.
Landaw SA
Semin Hematol; 1986 Apr; 23(2):156-65. PubMed ID: 3704667
[No Abstract] [Full Text] [Related]
10. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
[TBL] [Abstract][Full Text] [Related]
11. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
[TBL] [Abstract][Full Text] [Related]
12. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
13. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
Sánchez Fayos J; Prieto E; Román A; Soto de Ozaeta C; Nevado I; Richart A; Chica E; Loscertales J; Calabuig T; Benítez J; Outeiriño J
Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
[TBL] [Abstract][Full Text] [Related]
14. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
15. Morphometric study of the bone marrow in polycythemia vera following interferon-alpha therapy.
Franco V; Florena AM; Aragona F; Campesi G
Pathol Res Pract; 1993 Feb; 189(1):52-7. PubMed ID: 8516217
[TBL] [Abstract][Full Text] [Related]
16. Follow-up study on bone marrow reticulin fibrosis in AML.
Thiele J; Grashof K; Fisher R
Anal Cell Pathol; 1991 Jul; 3(4):225-31. PubMed ID: 1883746
[TBL] [Abstract][Full Text] [Related]
17. Polycythemia rubra vera.
Bilgrami S; Greenberg BR
Semin Oncol; 1995 Aug; 22(4):307-26. PubMed ID: 7638629
[TBL] [Abstract][Full Text] [Related]
18. Course and transformation of polycythaemia vera in relation to therapy.
Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
[TBL] [Abstract][Full Text] [Related]
19. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Rain JD
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
